These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25012174)

  • 1. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
    Blanchard A; Vargas-Poussou R; Vallet M; Caumont-Prim A; Allard J; Desport E; Dubourg L; Monge M; Bergerot D; Baron S; Essig M; Bridoux F; Tack I; Azizi M
    J Am Soc Nephrol; 2015 Feb; 26(2):468-75. PubMed ID: 25012174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eplerenone improved hypokalemia in a patient with Gitelman's syndrome.
    Ito Y; Yoshida M; Nakayama M; Tsutaya S; Ogawa K; Maeda H; Miyata M; Oiso Y
    Intern Med; 2012; 51(1):83-6. PubMed ID: 22214629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses.
    Roush GC; Ernst ME; Kostis JB; Yeasmin S; Sica DA
    J Hypertens; 2016 Jan; 34(1):11-9. PubMed ID: 26556568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
    Murdoch DL; Forrest G; Davies DL; McInnes GT
    Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension.
    White WB; Carr AA; Krause S; Jordan R; Roniker B; Oigman W
    Am J Cardiol; 2003 Jul; 92(1):38-42. PubMed ID: 12842242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
    Williams B; MacDonald TM; Morant SV; Webb DJ; Sever P; McInnes GT; Ford I; Cruickshank JK; Caulfield MJ; Padmanabhan S; Mackenzie IS; Salsbury J; Brown MJ;
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):464-475. PubMed ID: 29655877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
    Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome.
    Walsh SB; Unwin E; Vargas-Poussou R; Houillier P; Unwin R
    QJM; 2011 Nov; 104(11):939-44. PubMed ID: 21705784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride in Bartter's syndrome.
    Griffing GT; Komanicky P; Aurecchia SA; Sindler BH; Melby JC
    Clin Pharmacol Ther; 1982 Jun; 31(6):713-8. PubMed ID: 7075119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Indomethacin Treatment in a Chinese Child with Gitelman Syndrome: Case Report and Literature Review on its Efficacy and Tolerance.
    Peng X; Chen C; Tu J; Lin Y; Li H; Geng H
    Am J Case Rep; 2023 Dec; 24():e941627. PubMed ID: 38069462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 17 cases of Gitelman syndrome].
    Qu L; Zhang TT; Mu YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):432-4. PubMed ID: 22446001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT Interval in Adult with Chronic Hypokalemia due to Gitelman Syndrome: Not so Frequently Prolonged.
    Courand PY; Marques P; Vargas-Poussou R; Azizi M; Blanchard A;
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1640-1642. PubMed ID: 32792351
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome.
    Balavoine AS; Bataille P; Vanhille P; Azar R; Noël C; Asseman P; Soudan B; Wémeau JL; Vantyghem MC
    Eur J Endocrinol; 2011 Oct; 165(4):665-73. PubMed ID: 21753071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.